ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 166,83
-0,26%
Dow Jones
39 908,74
0,10%
DAX
18 712,47
-0,07%
Brent Oil
83,235
0,04%
Bitcoin
66 468,90
1,88%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Nastech Pharmaceutical Company (MM) (NSTK)

  7. Nastech Pharmaceutical Company (MM) (NSTK) Actualités

NSTK

Nastech Pharmaceutical Company (MM) (NSTK)

Nastech Pharmaceutical Company (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NSTK
DateHeureSourceTitreSymboleSociété
09/06/200820h31Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
09/06/200813h00Business WireNastech Announces Positive Intranasal Insulin Data at American Diabetes Association MeetingNASDAQ:NSTKNastech Pharmaceutical Company (MM)
15/05/200800h55Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
08/05/200822h05Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Quarterly Report (10-Q)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
08/05/200822h03Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
08/05/200822h00Business WireNastech Announces First Quarter 2008 Financial ResultsNASDAQ:NSTKNastech Pharmaceutical Company (MM)
01/05/200822h00Business WireNastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008NASDAQ:NSTKNastech Pharmaceutical Company (MM)
29/04/200819h50Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
25/04/200814h00Business WireNastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct OfferingNASDAQ:NSTKNastech Pharmaceutical Company (MM)
18/04/200812h04Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
27/03/200813h00Business WireNastech Pharmaceutical Company Inc. Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific AdvisoryNASDAQ:NSTKNastech Pharmaceutical Company (MM)
25/03/200817h41Business WireNastech Pharmaceutical Company Inc. to Present RNAi DataNASDAQ:NSTKNastech Pharmaceutical Company (MM)
21/03/200821h00Business WireNastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350(b)(1)(B)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
19/03/200802h36Business WireWall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company (NASDAQGM: NSTK)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
17/03/200821h09Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Annual Report (10-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
17/03/200821h00Business WireNastech Announces Fourth Quarter and Full Year 2007 Financial ResultsNASDAQ:NSTKNastech Pharmaceutical Company (MM)
13/03/200813h00Business WireNastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor ForumNASDAQ:NSTKNastech Pharmaceutical Company (MM)
11/03/200813h00Business WireNastech Pharmaceutical Company Inc. Completes Key RNAi Patent FilingsNASDAQ:NSTKNastech Pharmaceutical Company (MM)
07/03/200814h00Business WireNastech Pharmaceutical Company Inc. Announces Scientific Advisory Board for MDRNA, Inc., its Wholly-Owned RNAi SubsidiaryNASDAQ:NSTKNastech Pharmaceutical Company (MM)
29/02/200820h23PR Newswire (US)Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, MaNASDAQ:NSTKNastech Pharmaceutical Company (MM)
12/02/200820h05PR Newswire (US)Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate RestructuringNASDAQ:NSTKNastech Pharmaceutical Company (MM)
08/02/200819h40Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
05/02/200823h30Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Ownership (SC 13G)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
05/02/200814h00PR Newswire (US)Nastech Appoints MDRNA, Inc. Directors Strategic Advisory BoardNASDAQ:NSTKNastech Pharmaceutical Company (MM)
05/02/200812h00Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Notice of Effectiveness (EFFECT)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
22/01/200815h11Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Securities Registration Statement (simplified form) (S-3)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
08/01/200814h00PR Newswire (US)Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat ObesityNASDAQ:NSTKNastech Pharmaceutical Company (MM)
08/01/200813h30PR Newswire (US)Nastech Receives Notice of Allowance for U.S. Patent Related to Methods for Identifying Cell-Specific Targeting PeptidesNASDAQ:NSTKNastech Pharmaceutical Company (MM)
07/01/200814h00PR Newswire (US)Nastech Appoints Bruce R. York as Interim Chief Financial OfficerNASDAQ:NSTKNastech Pharmaceutical Company (MM)
20/12/200714h30PR Newswire (US)Nastech Announces Promotion of Gordon Brandt, M.D. to PresidentNASDAQ:NSTKNastech Pharmaceutical Company (MM)
 Showing the most relevant articles for your search:NASDAQ:NSTK

Dernières Valeurs Consultées

EU
RNO
Renault
COIN
BTCUSD
Bitcoin
EU
SGO
Cie de SaintGobain
EU
PX1
CAC 40
EU
BEL20
Bel 20
EU
CAP
Capgemini
USI
USTECH100
US Tech 100
FTSE
UKX
FTSE 100
EU
PX4
SBF 120
EU
GLE
Societe Generale
EU
VK
Vallourec
NYSE
MCD
McDonalds
EU
LR
Legrand
EU
EN
Bouygues
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés